期刊文献+

米拉贝隆和去羟基米拉贝隆的合成 被引量:3

Synthesis of Mirabegron and Dehydroxymirabegron
下载PDF
导出
摘要 以对硝基苯乙胺和(R)-环氧苯乙烷经开环、还原,与2-(2-氨基噻唑-4-基)乙酸直接缩合三步合成制备了治疗膀胱过度活动症原料药米拉贝隆,并以苯乙酰氯和对硝基苯乙胺为原料,经酰化、还原、缩合制得主要杂质去羟基米拉贝隆。所得目标化合物经红外、核磁共振氢谱、核磁共振碳谱和高分辨质谱等结构确证。改进后的米拉贝隆制备工艺反应条件温和、步骤短、操作简便,适合工业放大生产。 Over active bladder drug mirabegron was synthesized in three steps from( R)- phenyloxirane and 4-nitrophenethylamine by ring opening- substitution,reduction,and condensation with 2-( 2- aminothiazol- 4- yl) acetic acid. The main impurity,dehydroxymirabegron was also synthesized from phenylacetyl chloride and 4- nitrophenethylamine by acylation,reduction,and condensation. The structures of mirabegron and dehydroxymirabegron were confirmed by IR,1HNMR,13 CNMR and HRMS. The improved process has mild reaction conditions,short steps and simple operation,which is very suitable for amplification of production.
出处 《山东化工》 CAS 2016年第1期3-5,9,共4页 Shandong Chemical Industry
基金 吉林省医药产业发展专项资金计划项目基金(20130727044YY)
关键词 米拉贝隆 去羟基米拉贝隆 合成 mirabegron dehydroxymirabegron synthesis
  • 相关文献

参考文献7

  • 1Lam S,Hilas O.Pharmacologic management of overactive bladder[J].Clin Interv Aging,2007,2(3):337-345.
  • 2唐启东,宫平.米拉贝隆[J].中国药物化学杂志,2012,22(6):544-544. 被引量:18
  • 3范鸣.膀胱过度活动症治疗药Mirabegron[J].药学进展,2012,36(3):133-135. 被引量:8
  • 4Tatsuya M,Takayuki S,Kenichi O,et al.Antidiabetic,antilipemic,and hypoglycemic agents;adrenergic stimulants:US,6346532[P].2002-02-12.
  • 5Kawazoe S,Sakamoto K,Awamura Y,et al.Alpha-form or beta-form crystal of acetanilide derivative:EP,1440969[P].2002-10-29.
  • 6胡凡,王伸勇,贾新赞,等.一种米拉贝隆的合成方法:中国,103193730[P].2013-04-17.
  • 7章磊,谭支敏,焦慧荣,裘鹏程,张福利.米拉贝隆有关物质的合成[J].中国医药工业杂志,2014,45(1):9-12. 被引量:13

二级参考文献11

  • 1US Food and Drug Administration. FDA approves Myrbetriq for overactive bladder[EB/OL].[2012-6-28]. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm310096.html.
  • 2MARUYAMA T, SUZUKI T, ONDA K, et al. Amide derivatives or salts thereof: US, 6346532B1[P].2002-02-12.
  • 3TAKASU T, UKAI M, SATO S, et al. Effect of (R)-2-(2-aminothiazol-4-yl)-4’-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl} acetanilide (YM178), a novel selective β3-adrenoceptor agonist, on bladder function[J]. J Pharmacol Exp Ther, 2007, 321(2): 642-647.
  • 4TAKUSAGAWA S, VAN L, JAN J, et al. Absorption, metabolism and excretion of [14C]mirabegron (YM178), a potent and selective β3-adrenoceptor agonist, after oral administration to healthy male volunteers[J]. Drug Metab Dispos, 2012, 40(4): 815-824.
  • 5丸山龙也;铃木贵之;恩田健一.酰胺衍生物或其盐类[P]中国,12180451998.
  • 6Kawazoe S,Sakamoto K,Awamura Y. Alpha-form or beta-form crystal of acetanilide derivative[P].EP,1440969,2002.
  • 7胡凡;王伸勇;贾新赞.一种米拉贝隆的合成方法[P]中国,1031937302013.
  • 8Vrolix E,Goethals M,Zeegers-Huyskens T. Infrared study of hydrogen bond complexes involving 1,3-dimethyl-2-imidazolidinone and hydroxylic derivatives[J].{H}Spectroscopy Letters,1993,(3):497-507.
  • 9Martin NH,Jefford CW. Synthesis and photo-oxygenation of some substituted 1-benzyl-3,4-dihydroisoquinolines.Mechanism of enamine photo-oxygenation[J].{H}Helvetica Chimica Acta,1982,(3):762-774.
  • 10范鸣.膀胱过度活动症治疗药Mirabegron[J].药学进展,2012,36(3):133-135. 被引量:8

共引文献19

同被引文献20

  • 1胡凡,王伸勇,贾新赞,等.一种米拉贝隆的合成方法:中国,103193730[P].2013-04-17.
  • 2阿不都赛米·马木提,贲一飞.一种米拉贝隆的合成方法:104016943A[P].2014-09-03.
  • 3张华,李杨,陈仕杰.米拉贝隆的合成方法:103896872A[P].2014-07-02.
  • 4Takusagawa S, Van Lier J J, Suzuki K, et al. Absorption, metabolism and excretion of [(14)C]mirabegron (YM178), a patent and selective/3 (3)-adrenoceptor agonist, after oral administration to healthy male volunteers [J]. Drug Metabolism & Disposition the Biological Fate of Chemicals, 2012, 40(4): 815-824.
  • 5Takasu T, Ukai M, Sato S, et al. Effect of (R)-2-(2-aminothiazol- 4-yl)-4'-{2-[(2-hydroxy-2- phenylethyl)amino]ethyl acetanilide (YM178), a novel selective beta3-adrenoceptor agonist, on bladder function[J]. Journal of Pharmacology & Experimental Therapeutics, 2007, 321(2): 642-647.
  • 6Chapple C R, Nitti V W, Khullar V, et al. Onset of action of the 133- adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder [J]. World Journal of Urology, 2014, 32(6): 1 565-1 572.
  • 7Bhide A A, Digesu G A, Femando R, et al. Use of mirabegron in treating overactive bladder[J]. International Urogynecology Journal, 2012, 23(23): 1 345-1 348.
  • 8胡凡.一种米拉贝隆新的合成方法:中国,103304511A[P].2013-09-18.
  • 9Maruyama T 1. Amide derivatives or salts thereof: US, 6346532[P]. 2002-02-12.
  • 10Reid E B, Ruby W R. The synthesis of a lactone related to auxin bl [J]. Journal of the American Chemical Society, 2002, 73(3): 1 054- 1 061.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部